Boston Scientific | BSX - Net Income


Boston Scientific reported $1.34B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
AtriCure USD 108K 1.65M Mar/2026
Avanos Medical USD 5.1M 6.4M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 1.34B 669M Mar/2026
CONMED USD 13.83M 2.91M Mar/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Dexcom USD 199.5M 67.8M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Illumina USD 134M 200M Mar/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Masimo USD 57.1M 11.2M Mar/2026
Medtronic USD 1.24B 100M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Stryker USD 745M 104M Mar/2026
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026